Luis Peña, Evommune CEO
Evommune raises $50M to fund clinical trials in skin diseases
Evommune has raised a $50 million funding round that it plans to use to bankroll a series of clinical trials over …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
